Digestive Adaptation with Intestinal Reserve: A Neuroendocrine-Based Operation for Morbid Obesity

[1]  M. C. Velhote,et al.  Preliminary results from digestive adaptation: a new surgical proposal for treating obesity, based on physiology and evolution. , 2006, Sao Paulo medical journal = Revista paulista de medicina.

[2]  G. Ballantyne.  Peptide YY(1-36) and Peptide YY(3-36): Part I. Distribution, Release and Actions , 2006, Obesity surgery.

[3]  B. Ludvik,et al.  Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels , 2005, Obesity surgery.

[4]  T. Layden,et al.  CASE REPORT: Hepatic Decompensation After Gastric Bypass Surgery for Severe Obesity , 2004, Digestive Diseases and Sciences.

[5]  A. Patriti,et al.  The Enteroinsular Axis and the Recovery from Type 2 Diabetes after Bariatric Surgery , 2004, Obesity surgery.

[6]  MD Mph Charles Beymer,et al.  Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. , 2003, Archives of surgery.

[7]  Mohammad A Ghatei,et al.  Oxyntomodulin suppresses appetite and reduces food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[8]  Mohammad A Ghatei,et al.  Inhibition of food intake in obese subjects by peptide YY3-36. , 2003, The New England journal of medicine.

[9]  D. Drucker.  Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[10]  G. Bray.  The underlying basis for obesity: relationship to cancer. , 2002, The Journal of nutrition.

[11]  C. Destrieux,et al.  Anatomical study of the length of the human intestine , 2002, Surgical and Radiologic Anatomy.

[12]  J. Egan,et al.  Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  A. Luciani,et al.  Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  B. Göke,et al.  Effects of glucagon-like peptide-1(7–36)amide on motility and sensation of the proximal stomach in humans , 2002, Gut.

[15]  D. Palli,et al.  Fecal Levels of Short-Chain Fatty Acids and Bile Acids as Determinants of Colonic Mucosal Cell Proliferation in Humans , 2002, Nutrition and cancer.

[16]  W. Pan,et al.  Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier , 2002, Journal of Molecular Neuroscience.

[17]  S. Kumar,et al.  Resistin, central obesity, and type 2 diabetes , 2002, The Lancet.

[18]  E. Fábrega,et al.  Liver Transplantation in a Case of Steatohepatitis and Subacute Hepatic Failure after Biliopancreatic Diversion for Morbid Obesity , 2001, Obesity surgery.

[19]  P. Morange,et al.  Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. , 2000, Annals of medicine.

[20]  L. Baur,et al.  Fatty acids, triglycerides and syndromes of insulin resistance. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  J. Holst,et al.  Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity , 1997, International Journal of Obesity.

[22]  V. Marks,et al.  Attenuated GLP-1 secretion in obesity: cause or consequence? , 1996, Gut.

[23]  P. Layer,et al.  Ileal release of glucagon-like peptide-1 (GLP-1) , 1995, Digestive Diseases and Sciences.

[24]  L. Aiello,et al.  The Expensive-Tissue Hypothesis: The Brain and the Digestive System in Human and Primate Evolution , 1995, Current Anthropology.

[25]  A Fournier,et al.  Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. , 1995, The Journal of pharmacology and experimental therapeutics.

[26]  M. Lings,et al.  Articles , 1967, Soil Science Society of America Journal.

[27]  A. Baltasar,et al.  Clinical Hepatic Impairment after the Duodenal Switch , 2004, Obesity surgery.

[28]  E. Stankevičius,et al.  [Role of nitric oxide and other endothelium-derived factors]. , 2003, Medicina.

[29]  Manoel Carlos,et al.  Digestive adaptation: A new surgical proposal to treat obesity based on physiology and evolution Adaptação digestiva: Uma nova proposta cirúrgica para tratar a obesidade com base em fisiologia e evolução* , 2003 .

[30]  J. Holst,et al.  Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans , 1997 .

[31]  M. L. Robertson,et al.  Evolutionary perspectives on human nutrition: The influence of brain and body size on diet and metabolism , 1994, American journal of human biology : the official journal of the Human Biology Council.

[32]  J. Kowalczyk.  Comparative physiology of the vertebrate digestive system , 1988 .